Heron Therapeutics Announces Virtual Presentation at Evercore ISI 5th Annual HealthCONx Conference

SAN DIEGO, Nov. 21, 2022 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that…

Click here to view original post